Shenzhen Salubris Pharmaceuticals is a comprehensive pharmaceutical company.
Business Model:
Revenue: $5.1M
Employees: 1,001-5,000
Address: Shenzhen Shennan Road
City: Shenzhen
State: guangdong province
Zip: 518000
Country: CN
Shenzhen Salubris Pharmaceuticals Co., Ltd. (Salubris) is a comprehensive pharmaceutical company that integrates pharmaceutical products research and development, production and business sales, founded in 1998 and headquartered in Shenzhen, China.
Contact Phone:
Contact Email:
Listed Exchange:
SZSE
IPO Date:
9/10/2009
Ticker Symbol:
002294
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
12/2022 | Core Medical Technology | Series C | - |
1/2018 | KingstronBio | Series B | 19.5M |
8/2017 | GO Therapeutics | Equity | 5M |
3/2022 | SalubrisBio | Corporate Round | 32M |
6/2019 | Mercator MedSystems | Series D | 14.3M |
12/2018 | Viracta Therapeutics | Corporate Round | 0 |
1/2018 | Jinjiang Electronics | Corporate Round | - |
12/2016 | Zhongke Jiankang Wang | Angel Round | 431.9k |
3/2022 | SalubrisBio | Corporate Round | 0 |
6/2019 | Mercator MedSystems | Series D | 0 |
12/2018 | Viracta Therapeutics | Corporate Round | 0 |
1/2018 | KingstronBio | Series B | 0 |
8/2017 | GO Therapeutics | Funding Round | 0 |
12/2016 | Zhongke Jiankang Wang | Angel Round | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|